Business Context and Reporting Period
Company: InnovAge Holding Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: September 26, 2024
Reporting Period: Single event date (September 26, 2024)
The filing reports a corporate action regarding the Company's share repurchase program. InnovAge Holding Corp. is an emerging growth company incorporated in Delaware.
Key Financial Metrics
This filing does not contain comprehensive financial statements (revenue, profit, cash flow, or margins). The only financial data provided relates to the share repurchase program:
- Original Authorization (June 2024): $5.0 million
- Additional Authorization (September 2024): $2.5 million
- Total Authorized Amount: $7.5 million
- Shares Repurchased to Date: 837,372 shares
- Aggregate Market Value of Repurchased Shares: $5.0 million
Note: The filing text does not provide a clear value for current debt, liquidity, or operating margins.
Material Changes
The primary material change is the Board of Directors' decision to increase the share repurchase authorization by $2.5 million. This action follows the full utilization of the initial $5.0 million authorization approved in June 2024, under which the Company has already repurchased 837,372 shares.
Guidance, Outlook, and Risks
Management Commentary: The Company stated that future repurchases will depend on stock price, trading volume, corporate and regulatory requirements, and market conditions. Purchases may be made on the open market, in privately negotiated transactions, or via Rule 10b5-1 trading plans.
Risks and Contingencies: The Company explicitly noted it is not obligated to purchase any shares under the Program. The Program may be suspended or discontinued at any time without notice.
Investor Verification Checklist
- Verify the total remaining authorization under the share repurchase program ($2.5 million).
- Confirm the average price per share paid for the 837,372 shares repurchased to date ($5.0 million / 837,372 shares).
- Review the attached Press Release (Exhibit 99.1) for any additional strategic context regarding the capital allocation decision.
- Monitor future filings for actual execution of the additional $2.5 million authorization.